Application of continuous nursing based on timing theory in patients with atrial fibrillation and chronic heart failure
-
摘要:
目的 探讨基于时机理论的延续性护理干预对房颤合并慢性心力衰竭患者抗凝药物用药依从性及抗凝效果的影响。 方法 选取浙江省杭州市第一人民医院2019年1—6月收治的100例房颤合并慢性心衰患者,按随机数字表法分为观察组和对照组各50例,对照组患者实施常规护理及出院指导,观察组患者在对照组的基础上实施基于时机理论的延续性护理指导,比较2组患者出院后3、6个月后的抗凝药物服用依从性,国际标准化比值(INR)的达标情况以及并发症的发生情况。 结果 护理干预前,2组患者基本数据差异无统计学意义;护理干预后,观察组患者出院3个月后用药依从性评分(MMAS-8)为(7.42±0.87)分,明显高于对照组[(6.54±1.52)分,P=0.001],出院6个月复查其用药依从性评分[(7.33±0.89)分]亦高于对照组[(6.39±1.49)分,P=0.001];INR的达标率出院3个月后随访观察组明显高于对照组(P=0.009),出院6个月后达标率观察组较高,但与对照组比较差异无统计学意义(P=0.075);出院6个月后复查并发症的发生例数观察组(3例)低于对照组(9例),但差异无统计学意义(P=0.065)。 结论 通过对房颤合并慢性心力衰竭患者实施基于时机理论的科学全面的延续性护理,可以明显提高患者的服药依从性,提高患者的INR达标率,减少并发症,预后好,具有较高的临床价值。 Abstract:Objective To explore the effect of continuous nursing intervention based on timing theory on the compliance of anticoagulant medication and anticoagulant effect in patients with atrial fibrillation and chronic heart failure. Methods A total of 100 patients with atrial fibrillation and chronic heart failure admitted to Hangzhou First People's Hospital from January 2019 to June 2019 were selected. The patients were randomly divided into observation group and control group with 50 cases each. The patients in the control group were provided with routine nursing and discharge guidance. The patients in the observation group were provided with continuous nursing guidance based on the timing theory on the basis of the control group. Compliance with anticoagulant medication after 3 and 6 months discharge, International normalized ration (INR) compliance and complications were compared between the two groups. Results Before the nursing intervention, no significant difference in basic data was found between the two groups. After the nursing intervention, the medication compliance score (MMAS-8) of the observation group was significantly higher (7.42±0.87) than that of the control group (6.54±1.52, P=0.001) 3 months after the patients were discharged from the hospital. Six months after discharge, the medication compliance score (7.33±0.89) was also higher than that of the control group (6.39±1.49, P=0.001). The INR compliance rate of the 3-month follow-up observation group after discharge was significantly higher than that of the control group (P=0.009). The compliance rate 6 months after discharge was higher in the observation group than in the control group, but the difference was not significant (P=0.075). The number of complications in the follow-up examination 6 months after discharge (3 cases) was lower than that in the control group (9 cases), but the difference was not significant (P=0.065). Conclusion Implementing scientific and comprehensive continuation nursing based on timing theory for patients with atrial fibrillation and chronic heart failure can significantly improve the patient's medication compliance, increase the patient's INR compliance rate and reduce complications, leading to a good prognosis. Thus, this intervention is worthy of clinical application and promotion. -
Key words:
- Continuous nursing /
- Atrial fibrillation /
- Heart failure /
- Anticoagulation
-
表 1 2组房颤合并慢性心衰患者一般资料比较
Table 1. Comparison of general data of patients with atrial fibrillation complicated with chronic heart failure between two groups
组别 例数 性别(例) 年龄
(x±s, 岁)文化程度(例) 病程
(x±s,年)合并高血压(例) 合并冠心病(例) 男性 女性 文盲 小学 中学 中专/高中 大学 观察组 50 34 16 63.10±10.60 3 11 14 13 9 3.25±2.04 10 14 对照组 50 33 17 66.54±10.43 3 11 13 9 14 3.60±2.09 12 15 统计量 0.045a -1.636b 1.864a -1.284b 0.233a 0.049a P值 0.832 0.105 0.761 0.205 0.629 0.826 注:a为χ2值,b为t值。 表 2 2组房颤合并慢性心衰患者的服药依从性MMAS-8评分比较(x ±s,分)
Table 2. Comparison of medication compliance MMAS-8 score between two groups of patients with atrial fibrillation complicated with chronic heart failure
组别 例数 3个月 6个月 t值 P值 观察组 50 7.42±0.87 7.33±0.89 1.838 0.072 对照组 50 6.41±1.62 6.39±1.49 0.112 0.911 t值 3.851 3.666 P值 < 0.001 0.001 表 3 2组房颤合并慢性心衰患者出院3、6个月后INR值监测情况比较(例)
Table 3. Comparison of INR values of patients with atrial fibrillation complicated with chronic heart failure in 2 groups 3 and 6 months after discharge
组别 例数 出院后3个月INR值 出院后6个月INR值 <2.0 2.0~3.0 >3.00 <2.0 2.0~3.0 >3.00 观察组 50 8 42 0 10 40 0 对照组 50 18 30 2 20 26 4 U值 2.580 1.778 P值 0.010 0.075 表 4 2组房颤合并慢性心衰患者并发症发生率比较[例(%)]
Table 4. Comparison of complication rate between two groups of patients with atrial fibrillation complicated with chronic heart failure
组别 例数 牙龈出血 鼻腔出血 眼底出血 合计 观察组 50 2(4.0) 1(2.0) 0 3(6.0) 对照组 50 5(10.0) 2(4.0) 2(4.0) 9(18.0) χ2值 0.614 < 0.001 3.409 P值 0.433 0.999 0.495a 0.065 注:a为采用Fisher精确检验。 -
[1] 黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志, 2018, 22(4): 315-368. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201804002.htmHUANG C X, ZHANG S, HUANG D J, et al. Current knowledge and management of atrial fibrillation: consensus of Chinese experts 2018[J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2018, 22(4): 315-368. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201804002.htm [2] 郭豫涛. 中国老年心房颤动临床流行病学和抗栓管理现状及变化[J]. 中华老年心脑血管病杂志, 2017, 19(9): 988-990. doi: 10.3969/j.issn.1009-0126.2017.09.024GUO Y T. Clinical epidemiology and antithrombotic management of atrial fibrillation in the elderly in China[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2017, 19(9): 988-990. doi: 10.3969/j.issn.1009-0126.2017.09.024 [3] 严婷. 心房颤动并发左心房血栓形成的危险因素分析[J]. 中国基层医药, 2020, 27(16): 1974-1978. doi: 10.3760/cma.j.issn.1008-6706.2020.16.013YAN T. Risk factors of atrial fibrillation complicated with left atrial thrombosis[J]. Chinese Journal of Primary Medicine and Pharmacy, 2020, 27(16): 1974-1978. doi: 10.3760/cma.j.issn.1008-6706.2020.16.013 [4] 刘鸿亚, 王玲. 房颤的发病机制及其合并心衰的相关性研究[J]. 疾病监测与控制杂志, 2018, 12(2): 139-143. https://www.cnki.com.cn/Article/CJFDTOTAL-JBJK201802018.htmLIU H Y, WANG L. Study on the relation between pathogenesis of atrial fibrillation and combined heart failure[J]. Journal of Diseases Monitor & Control, 2018, 12(2): 139-143. https://www.cnki.com.cn/Article/CJFDTOTAL-JBJK201802018.htm [5] 赵玉红, 陈凯峰, 田蔚然, 等. 华法林对老年持续性房颤患者的疗效[J]. 心血管康复医学杂志, 2020, 29(1): 98-100. doi: 10.3969/j.issn.1008-0074.2020.01.24ZHAO Y H, CHEN K F, TIAN W R, et al. Therapeutic effect of warfarin on aged patients with persistent atrial fibrillation[J]. Chinese Journal of Cardiovascular Rehabilitation Medicine, 2020, 29(1): 98-100. doi: 10.3969/j.issn.1008-0074.2020.01.24 [6] 陈强, 曲珊珊, 黄欣. 中文版MMAS-8评价心血管慢病患者用药依从性的信效度分析与实践[J]. 中国药房, 2019, 30(2): 268-271. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201902026.htmCHEN Q, QU S S, HUANG X. Analysis and practice of reliability and validity evaluation of medication compliance in patients with chronic cardiovascular disease by chinese version of MMAS-8[J]. China Pharmacy, 2019, 30(2): 268-271. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201902026.htm [7] 冯广迅, 杨艳敏, 朱俊, 等. 心房颤动伴或不伴心力衰竭患者的死亡危险因素分析[J]. 中国循环杂志, 2018, 33(2): 161-165. doi: 10.3969/j.issn.1000-3614.2018.02.013FENG G X, YANG Y M, ZHU J, et al. Analysis for risk factors of death in atrial fibrillation patients with or without heart failure[J]. Chinese Circulation Journal, 2018, 33(2): 161-165. doi: 10.3969/j.issn.1000-3614.2018.02.013 [8] 刘松涛, 罗潇, 李萍. 心房颤动上游治疗的研究进展[J]. 中华全科医学, 2018, 16(11): 1886-1889. doi: 10.16766/j.cnki.issn.1674-4152.000514LIU S T, LUO X, LI P. Research progress in upstream treatment of atrial fibrillation[J]. Chinese Journal of General Practice, 2018, 16(11): 1886-1889 doi: 10.16766/j.cnki.issn.1674-4152.000514 [9] CERASUOLO J O, MONTERO_ODASSO M, IBANEZ A, et al. Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami[J]. Int J Stroke, 2017, 12(3): 222-228. doi: 10.1177/1747493016687579 [10] BAI Y, WANG Y L, SHANTSILA A, et al. The global burden of atrial fibrillation and stroke: A systematic review of the clinical epidemiology of atrial fibrillation in Asia[J]. Chest, 2017, 152(4): 810-820. doi: 10.1016/j.chest.2017.03.048 [11] 张博, 陈肖敏. 我国"互联网+"延续性护理的Meta分析[J]. 浙江临床医学, 2020, 22(5): 677-679. https://www.cnki.com.cn/Article/CJFDTOTAL-DZZZ201305142.htmZHANG B, CHEN X M. Meta-analysis of "Internet +" transitional care in China[J]. Zhejiang Clinical Medical Journal, 2020, 22(5): 677-679. https://www.cnki.com.cn/Article/CJFDTOTAL-DZZZ201305142.htm [12] 秦庆祝, 李一聪, 范晓青. 时机理论对PCI患者自我管理行为和服药依从性的影响[J]. 中华现代护理杂志, 2019, 25(16): 2058-2060. doi: 10.3760/cma.j.issn.1674-2907.2019.16.019QIN Q Z, LI Y C, FAN X Q. Application effect of timing theory on self-management and medication adherence in patients with percutaneous coronary intervention[J]. Chinese Journal of Modern Nursing, 2019, 25(16): 2058-2060. doi: 10.3760/cma.j.issn.1674-2907.2019.16.019 [13] 陆少青, 黎海莲, 叶焕. 精准护理在规范管理心房颤动患者华法林抗凝治疗中的应用[J]. 临床医学工程, 2019, 26(6): 837-838. doi: 10.3969/j.issn.1674-4659.2019.06.0837LU S Q, LI H L, YE H. Application of precise nursing in the standardized management of warfarin anticoagulation therapy for patients with A-trial fibrillation[J]. Clinical Medical & Engineering, 2019, 26(6): 837-838. doi: 10.3969/j.issn.1674-4659.2019.06.0837 [14] 张燕, 刘媛. 延续性护理在慢性房颤合并2型糖尿病患者抗凝治疗中的效果研究[J]. 当代护士(下旬刊), 2017, 12(10): 57-59. https://www.cnki.com.cn/Article/CJFDTOTAL-DDHZ201710028.htmZHANG Y, LIU Y. Effect of continuous nursing on anticoagulant therapy in patients with chronic atrial fibrillation complicated with type 2 diabetes mellitus[J]. Today Nurse, 2017, 12(10): 57-59. https://www.cnki.com.cn/Article/CJFDTOTAL-DDHZ201710028.htm [15] 魏舒. 综合护理干预对阵发性房颤射频消融患者心理和生活质量的影响[J]. 河北医药, 2015, 37(17): 2712-2714. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201517056.htmWEI S. Effects of comprehensive nursing intervention on psychology and quality of life in patients with paroxysmal atrial fibrillation undergoing radiofrequency ablation[J]. Hebei Medical Journal, 2015, 37(17): 2712-2714. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201517056.htm [16] 李东波, 王飞, 夏砚. 延续性护理干预对老年糖尿病患者疾病转归的影响[J]. 浙江临床医学, 2019, 21(9): 1281-1282.LI D B, WANG F, XIA Y. Effect of continuous nursing intervention on disease transformation in elderly patients with diabetes mellitus[J]. Zhejiang Clinical Medical Journal, 2019, 21(9): 1281-1282.
计量
- 文章访问数: 183
- HTML全文浏览量: 64
- PDF下载量: 1
- 被引次数: 0